CLINSQUARE: CLINICAL RESEARCH COURSES
Saturday, April 19, 2025
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home2020April

Monthly Archives: April, 2020

ViiV Healthcare announces £3 million global fund to research the impact of COVID-19 on the HIV community and fill gaps in prevention, treatment and...

admin - 0
April 27, 2020: "ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders announced the creation...

Can an existing HIV medication slow the spread of COVID-19?

admin - 0
April 28, 2020: A team of scientists from St. Michael's Hospital, Sinai Health and Sunnybrook Health Sciences Centre have launched a clinical trial to...

Novartis announces plan to initiate clinical trial of canakinumab for patients with COVID-19 pneumonia

admin - 0
April 28, 2020: "Novartis announced plans to initiate a Phase III clinical trial to study canakinumab in patients with COVID-19 pneumonia. The CAN-COVID trial...

Neurocrine Biosciences Announces FDA Approval of Once-Daily ONGENTYS® (opicapone) as an Add-On Treatment for Patients with Parkinson’s Disease Experiencing “Off” Episodes

admin - 0
April 27, 2020: "Neurocrine Biosciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved once-daily oral ONGENTYS® (opicapone) 25 mg and 50...

Sanofi and Regeneron provide an update on U.S. Phase 2/3 adaptive-designed trial of Kevzara® (sarilumab) in hospitalized COVID-19 patients

admin - 0
April 27, 2020:" Sanofi and Regeneron Pharmaceuticals, Inc. announced the preliminary results from the Phase 2 portion of an ongoing Phase 2/3 trial evaluating Kevzara® (sarilumab), an interleukin-6 (IL-6)...

Sanofi: Phase 3 trial of Libtayo® (cemiplimab) as monotherapy for first-line advanced non-small cell lung cancer stopped early due to highly significant improvement in...

admin - 0
April 27, 2020: "Sanofi and Regeneron Pharmaceuticals, Inc. announced the primary endpoint of overall survival (OS) was met in a Phase 3 trial comparing the PD-1 inhibitor Libtayo® (cemiplimab)...

Coronavirus (COVID-19) Update: FDA Continues to Ensure Availability of Alcohol-Based Hand Sanitizer During the COVID-19 Pandemic, Addresses Safety Concerns

admin - 0
April 27, 2020: "The U.S. Food and Drug Administration provided an update on its efforts to ensure the availability of alcohol-based sanitizer to...

FDA Warns Manufacturers and Retailers to Remove Certain E-cigarette Products Targeted to Youth from the Market

admin - 0
April 27, 2020: "The U.S. Food and Drug Administration issued ten warning letters to retailers and manufacturers who sell, manufacture and/or import unauthorized...

Novacyt contract with the UK Department of Health and Social Care for the supply of COVID-19 PCR tests

admin - 0
April 27, 2020: Novacyt, an international specialist in clinical diagnostics, announces it has signed a supply contract with the UK Department of Health and...

FDA Warns of Heart Risks With Trump-Promoted Malaria Drug

admin - 0
April 24, 2020: "The U.S. Food and Drug Administration on Friday warned doctors against prescribing a malaria drug touted by President Donald Trump for...

FDA approves MenQuadfiTM, the latest innovation in meningococcal (MenACWY) vaccination

admin - 0
April 24, 2020: "The U.S. Food and Drug Administration (FDA) has approved a Biologics License Application for MenQuadfiTM Meningococcal (Groups A, C, Y, W) Conjugate...

Global leaders unite to ensure everyone everywhere can access new vaccines, tests and treatments for COVID-19

admin - 0
April 24, 2020: GENEVA - Heads of state and global health leaders today made an unprecedented commitment to work together to accelerate the...
123...10Page 2 of 10
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved